Results 31 to 40 of about 1,396,646 (189)

The Distributed Partnering Model for Drug Discovery and Development [PDF]

open access: yes, 2010
Proposes a model for bringing new drugs to market efficiently by creating "product definition companies" that would acquire early-stage discoveries from research institutions and invest in defining product applications to sell to pharmaceutical ...
Duane Roth, Pedro Cuatrecasas
core   +1 more source

Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway

open access: yesParasites & Vectors, 2016
Background In the fight against malaria, the discovery of chemical compounds with a novel mode of action and/or chemistry distinct from currently used drugs is vital to counteract the parasite’s known ability to develop drug resistance. Another desirable
Sabine Fletcher   +6 more
doaj   +1 more source

Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase

open access: yesScientific Reports, 2022
While the prevalence of breast cancer metastasis in the brain is significantly higher in triple negative breast cancers (TNBCs), there is a lack of novel and/or improved therapies for these patients. Monoacylglycerol lipase (MAGL) is a hydrolase involved
Othman Benchama   +5 more
doaj   +1 more source

Protein Functional Families to characterise drug-target interactions. [PDF]

open access: yes, 2017
The quest for “magic bullets” has been the driving force in drug discovery during the last two decades. However, the increasing rate of drug failure over this period has occurred concurrently with the assumption that a drug is a selective ligand for a ...
Moya-García, Aurelio
core  

Benchmarking network propagation methods for disease gene identification [PDF]

open access: yes, 2019
In-silico identification of potential target genes for disease is an essential aspect of drug target discovery. Recent studies suggest that successful targets can be found through by leveraging genetic, genomic and protein interaction information.
Barrett, Steven J.   +5 more
core   +2 more sources

Discovery and binding mode of small molecule inhibitors of the apo form of human TDO2

open access: yesScientific Reports
Tryptophan-2,3-dioxygenase (TDO2) and indoleamine-2,3-dioxygenase (IDO1) are structurally distinct heme enzymes that catalyze the conversion of L-tryptophan to N-formyl-kynurenine, and play important roles in metabolism, inflammation, and tumor immune ...
Carina Lotz-Jenne   +12 more
doaj   +1 more source

A novel anti-NGF PEGylated Fab’ provides analgesia with lower risk of adverse effects

open access: yesmAbs, 2023
Nerve growth factor (NGF) has emerged as a key driver of pain perception in several chronic pain conditions, including osteoarthritis (OA), and plays an important role in the generation and survival of neurons.
Yukari Koya   +8 more
doaj   +1 more source

Bayer AG v. Housey Pharmaceuticals: Protection for Biotechnological Research Tools under Section 271(g) Found Wanting [PDF]

open access: yes, 2005
[Excerpt] Research tools, a subset of biotechnological inventions protected by process patents, are “tools that scientists use in the laboratory, including cell lines, monoclonal antibodies, reagents, animal models, growth factors, combinatorial ...
Barthalow, Matthew
core   +1 more source

Capturing mixture composition: an open machine-readable format for representing mixed substances

open access: yesJournal of Cheminformatics, 2019
We describe a file format that is designed to represent mixtures of compounds in a way that is fully machine readable. This Mixfile format is intended to fill the same role for substances that are composed of multiple components as the venerable Molfile ...
Alex M. Clark   +3 more
doaj   +1 more source

Hot-spot analysis for drug discovery targeting protein-protein interactions [PDF]

open access: yes, 2018
Introduction: Protein-protein interactions are important for biological processes and pathological situations, and are attractive targets for drug discovery. However, rational drug design targeting protein-protein interactions is still highly challenging.
Fernández-Recio, Juan, Rosell, Mireia
core   +2 more sources

Home - About - Disclaimer - Privacy